Global News

Sellas believes GPS-treated AML patients could live longer than those receiving standard treatment, with a projected survival of about 12.6 months versus 8 months.

ASTS confirmed that BlueBird 9 arrived at Cape Canaveral ahead of its next Falcon 9 launch with SpaceX.

Smaller space stocks surged after NASA outlined plans for near-monthly moon missions starting in 2027.

CEO William Li said earlier that Nio expects deliveries in May and June to improve steadily, driven by the ES9 launch and the recently introduced Onvo L80.

Last week, AMD announced a $10 billion investment in Taiwan to boost manufacturing partnerships in that country, which is home to the world’s largest contract chip manufacturer, TSMC.

Destiny Tech100 announced plans for a new $1 billion at-the-market stock offering and warned investors about share-price volatility and premium valuation risks.

Musk fueled excitement by calling for a “major base on the Moon” and calling lunar and Martian colonies SpaceX’s “prime directive.”

BofA cut its HIMS price target to $25 from $28, while warning that the company’s 2026 outlook depends on a “significant” ramp-up in GLP-1 growth.

Sellas will participate Wednesday in TD Cowen’s Oncology Innovation Summit, marking the final major conference appearance ahead of the Regal data release.

Europe’s “tech sovereignty” push has drawn fresh attention to Satellite Connect Europe, AST SpaceMobile’s joint venture with Vodafone.

Momentus said the market value of its outstanding shares was $79.8 million, based on its highest Nasdaq closing price over the previous 60 days.

The former President of the Federal Reserve Bank of New York pointed to rising long-term inflation expectations as a sign that Americans may be starting to doubt the Fed’s ability to control inflation.

The Roundhill Memory ETF (DRAM) declined 1.5% in Friday’s premarket session, tracking a 2.3% drop in Samsung shares in Seoul on Friday.

Prediction market traders currently see the highest odds for a SpaceX debut valuation between $2 trillion and $2.5 trillion.

AMD CEO Lisa Su said that the company is working with its vendors in Taiwan to ramp up production amid a stronger-than-expected demand for CPUs.

SpaceX accounts for 16.2% of DXYZ’s portfolio, while VCX holds Anthropic at 20.7%, OpenAI at 9.9% and SpaceX at 5%.

The launch follows Novo Nordisk’s failure to pay a C$250 patent maintenance fee in Canada.

Retail speculation intensified as short interest in SLS climbed to a record high of 30.7% ahead of the final Regal catalyst.

CEO William Li said Nio is prioritizing margins and profitability over chasing delivery growth through discounts.

The contract came ahead of Rocket Lab’s “Viva La StriX” Electron launch mission for Synspective from New Zealand.

Ives said combining Tesla’s autonomous-driving data with SpaceX’s satellite and AI infrastructure could create an “unmatched” competitive edge.

AST SpaceMobile gained attention after SpaceX identified the company as a competitor in satellite-to-mobile connectivity.

Beyond leukemia, Sellas said GPS could potentially expand into up to 20 different tumor types.

Munster said Nvidia and SpaceX together could have a combined $7 trillion market cap.

The filing revealed that Tesla owns nearly 19 million Class A shares of SpaceX as of May 1.

Samsung and its union reached a last-minute pay deal just before the strike was set to begin. Union members will now vote on the agreement and decide whether to proceed with the strike plan or drop it.

Nio is also spotlighting its upcoming ES9 SUV ahead of earnings, with the company set to showcase its SkyRide suspension tech.

Space stocks were also pressured by SpaceX's IPO prospectus, dragging ASTS, LUNR, FLY lower, along with RKLB.

U.S. equity markets rallied sharply on Wednesday after President Donald Trump indicated that a potential agreement with Iran could be within reach.

TSLA’s forward PEG ratio stands at 6x versus 1.8x for NVIDIA, 1.5x for Alphabet, 1.2x for Meta and 1.6x for Amazon.

The CEO said topline Regal data could arrive within weeks after the final 80th event, once data cleaning and final review processes are completed.

The controversy fueled speculation that Onvo may have resorted to reactive discounting amid China’s intense EV price war and rising competition.

Veteran investor Ron Baron revealed plans for a $1 billion SpaceX IPO investment and said the company could become “the largest company on the planet.”

The options market implies a potential $3.5 billion one-day swing for short sellers after earnings.

ASTS, RKLB and LUNR continued drawing attention through satellite rollouts, launch programs, and NASA contracts.

ImmunityBio said the FDA is focusing on evidence suggesting that papillary bladder cancer and CIS are biologically similar diseases.

In another poll by retail influencer AleXandra Merz, 69% of traders said they would use cash to fund potential SpaceX purchases.

Investors are focused on the intensifying premium EV battle in China as models from Nio, XPeng, Aito and Denza compete aggressively.

Hims priced $350 million of 0.00% convertible senior notes due 2032 and granted buyers an option to purchase an additional $52.5 million in notes.

CEO William Li said Nio currently has no plans to launch additional Firefly models since the brand already controls 70% of China’s premium compact EV segment.

CEO David A. Dodd said GEO-MVA remains central to GeoVax’s biodefense and vaccine supply strategy.

Nvidia said the first Vera CPU systems were delivered to Anthropic, OpenAI and SpaceXAI, the combined AI entity in Musk’s xAI and SpaceX ecosystem.

AST SpaceMobile said two BlueBird satellites are already en route to Cape Canaveral, with a third “close behind.”

Investors are watching several upcoming oncology conferences this month for potential pipeline and regulatory updates.

Berkshire originally built the UNH stake during the healthcare giant’s 2025 selloff, with the investment later valued at $1.6 billion.

Deutsche Bank expects Onvo L80 sales to initially reach 10,000 units per month before normalizing toward 4,000 units.

SpaceX reportedly completed a 5-for-1 stock split ahead of the listing, lowering the implied share price to about $105.

Wall Street analysts increasingly view SATS as a retail proxy trade for SpaceX exposure.

Elon Musk said over the weekend that he is “not selling any” SpaceX shares.

Founder Patrick Soon-Shiong said Monday’s FDA workshop could address key questions related to ImmunityBio’s pending Anktiva expansion filing.